ИСТИНА |
Войти в систему Регистрация |
|
ФНКЦ РР |
||
The growth of most breast cancers depends on estrogens. The hormone therapy is aimed at reducing the effect of estrogens and their receptors on tumor cells and suppressing the rate of tumor growth. The androgen receptor, another steroid receptor, is a novel potential target in breast cancer cells. The work aims to develop selective androgen receptor inhibitors with proapoptotic activity.